Stock AnalysisJuly 15, 2026 · 5 min read

Is Revvity Stock (RVTY) Halal? A Complete Analysis

Revvity (formerly PerkinElmer's life-sciences and diagnostics businesses) supplies research tools and diagnostics. Advancing science and healthcare is permissible; the verdict depends on the acquisition-related debt screen. Here is the full breakdown.

Time-sensitive screening snapshot: financial ratios and business mix can change after each filing. This is educational research, not a fatwa or investment advice. Verify the latest filing and your preferred Sharia standard before acting.

The Short Answer

Revvity stock (RVTY) is generally considered halal for Muslim investors, subject to the balance-sheet ratios. Revvity — the company formed from the former PerkinElmer's life-sciences and diagnostics businesses — provides reagents, instruments, software, and diagnostics used in research, drug discovery, and clinical testing, including newborn screening and immunodiagnostics. Supplying tools and diagnostics that advance science and healthcare is a permissible activity, so the business-activity screen passes.

Current quantitative Sharia screen

Based on 10-Q figures for the period ended 2026-04-05; calculated 2026-07-15.

USD · millions
Interest-bearing debt / assets
26.89%Within limit
Below 33.333% under FTSE Yasaar

3,226.15 / 11,996.59

Cash + interest-bearing securities / assets
7.17%Within limit
Below 33.333% under FTSE Yasaar

860.32 / 11,996.59

Receivables + cash / assets
12.93%Within limit
Below 50% under FTSE Yasaar

1,551.7 / 11,996.59

Non-compliant income / revenue
0.89%Within limit
No more than 5% under FTSE Yasaar

6.304 / 711.118

FTSE Yasaar
v4.6, February 2026
Financial
Pass
Overall
Incomplete

Debt/assets is 26.89%, liquidity/assets is 7.17%, receivables plus cash/assets is 12.93% and interest income/revenue is 0.89%, below the examined limits; activity remains incomplete.

MSCI Islamic (total-assets series)
October 2024 methodology
Financial
Pass
Overall
Incomplete

Debt/assets is 26.89%, liquidity/assets is 7.17% and receivables plus cash/assets is 12.93%, below the examined MSCI limits; activity remains incomplete.

Malaysia SAC financial ratios
single 5% activity benchmark adopted November 2025
Financial
Pass
Overall
Incomplete

Debt/assets and liquidity/assets are below the examined Malaysia SAC limits; activity remains incomplete and this is not an official classification.

Market-cap denominator methods
MSCI M-Series, S&P and Dow Jones methods differ
Financial
Not calculated
Overall
Incomplete

A licensed historical market-cap series is not stored, so market-cap denominator methods are not estimated from a current spot price.

Business-activity disclosure

Revvity provides life-sciences instruments, reagents, software and diagnostics used in research and clinical testing. Scientific and healthcare tools are generally permissible, while customer end uses, acquisitions and product-level exposures require continuing review.

Limitation: The filing does not allocate every research, diagnostics, customer or acquisition-related revenue stream into a universal prohibited-activity numerator.

Purification

Revvity discloses $6.304 million of investment income interest, but no scholar-approved purification percentage is inferred.

Inputs, assumptions and primary sources
  • Amounts are USD millions from Revvity's April 5, 2026 Form 10-Q.
  • Debt uses $3,226.15 million of combined current and long-term debt; operating leases are excluded.
  • Cash and cash equivalents are $860.32 million; no separate interest-bearing securities balance is added from the extracted facts.
  • Accounts receivable, net is $691.38 million and first-quarter revenue is $711.118 million.
  • Investment income interest is $6.304 million; the filing does not provide a universal prohibited-revenue numerator for research, diagnostics or customer end uses.

This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.

The latest Form 10-Q (period ended April 5, 2026) reports $3,226.150 million of debt against $11,996.590 million of assets. Debt/assets is 26.89%, while receivables-plus-cash/assets is 12.93%; the known asset-based tests pass, subject to methodology and business-activity review.

Sharia Screening Methodology

Islamic scholars use several criteria to screen stocks:

  • Business activity screen: Is the company's primary business halal?
  • Debt ratio: Total debt / market cap must be under 33%
  • Interest income: Interest income / total revenue must be under 5%
  • Haram revenue: Revenue from haram sources must be under 5%
  • Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)

What Revvity Does

Revvity, Inc. (headquartered in Waltham, Massachusetts) operates across life sciences and diagnostics:

  • Life sciences: Reagents, instruments, and software for research and drug discovery.
  • Diagnostics: Newborn screening, immunodiagnostics, and applied genomics.
  • Software and informatics: Signals and other data platforms for scientific workflows.

Supplying tools and diagnostics that advance science and healthcare is a permissible activity, so the business-activity screen passes.

Why It Passes (and What to Check)

1. Permissible Core Business

Revvity's revenue comes from research tools and diagnostics — a clearly permissible activity that benefits science and healthcare. There is no haram revenue line.

2. Debt Ratio (Deciding Screen)

Revvity has grown through acquisitions and carries interest-bearing debt, so confirm the total-debt-to-market-cap ratio against the 33% threshold using the latest filings. This is a deciding screen for the verdict.

3. Interest Income (Purify)

Revvity earns incidental interest income on its cash balances. This should be checked against the 5% threshold and the corresponding portion of returns purified.

Current Quantitative Screen (April 5, 2026)

  • Debt / assets: 26.89% — $3,226.150 million / $11,996.590 million
  • Cash / assets: 7.17% — $860.320 million / $11,996.590 million
  • Receivables + cash / assets: 12.93% — $1,551.700 million / $11,996.590 million
  • Interest income / revenue: 0.89% — $6.304 million / $711.118 million

These figures pass the displayed FTSE Yasaar asset-based limits. Market-cap denominators and complete prohibited-activity review are school- and data-dependent, so this is a reproducible research screen rather than an outside-agency classification.

What About Purification?

Purify the portion of returns attributable to interest income earned on Revvity's cash balances — donating that share of gains to charity.

How to Read the Result

The quantitative figures support a HALAL research result under the displayed asset-based tests. Revvity's life-sciences and diagnostics business is qualitatively permissible on the information reviewed; purify disclosed interest income and re-screen after new filings.

Bottom Line

Revvity (RVTY) is generally halal for Muslim investors, subject to the balance-sheet ratios. The life-sciences and diagnostics business is clearly permissible. Confirm the debt and receivables ratios against the latest filings — acquisitions make the debt screen the one to watch — purify the interest income, and re-screen periodically.

🔍 Check Other Stocks

Want to check if another stock is halal? Use our free screener.

Open Halal Checker →
RVTY verdict card: HALAL — current screening available — screening summary, concerns & similar assetsView →
⏭ Up Next
What Makes a Stock Halal?

How do Islamic scholars determine if a stock is halal? Learn the 4 Sharia screening criteria used by major Islamic indices and how to apply them yours...

Read it now
💰
Already know you want to invest halal?
Get 50% off Islamicly — comprehensive halal screening + digital gold + portfolios.
Use code:ZAKAT50→ 50% OFF
Use Code ZAKAT50 →
📋

Get the Free 5-Minute Halal Stock Checklist

The 4 screens scholars use, with thresholds — plus occasional halal investing insights. No spam. Unsubscribe anytime.